CH525193A - Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen - Google Patents

Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Info

Publication number
CH525193A
CH525193A CH880769A CH880769A CH525193A CH 525193 A CH525193 A CH 525193A CH 880769 A CH880769 A CH 880769A CH 880769 A CH880769 A CH 880769A CH 525193 A CH525193 A CH 525193A
Authority
CH
Switzerland
Prior art keywords
compounds
preparation
acid production
gastric acid
inhibit gastric
Prior art date
Application number
CH880769A
Other languages
English (en)
Inventor
Elof Brandstrom Arne
Krister Junggren Ulf
Robert Lamm Bo
Erik Wilander Bengt
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to CH1500671A priority Critical patent/CH534133A/de
Priority to CH1500571A priority patent/CH534668A/de
Priority to CH1500371A priority patent/CH534667A/de
Publication of CH525193A publication Critical patent/CH525193A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH880769A 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen CH525193A (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH1500671A CH534133A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH1500571A CH534668A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH1500371A CH534667A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2778768A GB1279412A (en) 1968-06-11 1968-06-11 Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion

Publications (1)

Publication Number Publication Date
CH525193A true CH525193A (de) 1972-07-15

Family

ID=10265313

Family Applications (2)

Application Number Title Priority Date Filing Date
CH880769A CH525193A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH1500471A CH539021A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1500471A CH539021A (de) 1968-06-11 1969-06-10 Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen

Country Status (11)

Country Link
AT (6) AT293430B (de)
BE (1) BE734033A (de)
BR (1) BR6909672D0 (de)
CH (2) CH525193A (de)
DE (1) DE1929416A1 (de)
DK (1) DK126035B (de)
ES (3) ES368207A1 (de)
FR (2) FR2010650B1 (de)
GB (1) GB1279412A (de)
IE (1) IE33149B1 (de)
NL (1) NL6908843A (de)

Also Published As

Publication number Publication date
AT293428B (de) 1971-10-11
BE734033A (de) 1969-11-17
CH539021A (de) 1973-08-31
NL6908843A (de) 1969-12-15
IE33149L (en) 1969-12-11
ES368207A1 (es) 1972-04-16
FR2140246A1 (de) 1973-01-12
FR2010650A1 (de) 1970-02-20
DE1929416A1 (de) 1970-07-16
AT292012B (de) 1971-08-10
ES388703A1 (es) 1974-02-16
BR6909672D0 (pt) 1973-03-13
GB1279412A (en) 1972-06-28
ES388702A1 (es) 1973-05-16
FR2010650B1 (de) 1975-01-10
AT293429B (de) 1971-10-11
AT294849B (de) 1971-12-10
DK126035B (da) 1973-06-04
IE33149B1 (en) 1974-04-03
AT298667B (de) 1972-05-25
AT293430B (de) 1971-10-11

Similar Documents

Publication Publication Date Title
CH556319A (de) Verfahren zur herstellung von neuartigen substituierten trizyklischen carbonsaeureverbindungen.
CH556329A (de) Verfahren zur herstellung von cyanacrylsaeureestern.
CH496641A (de) Verfahren zur Herstellung von Lavandulylsäure
CH552551A (de) Verfahren zur herstellung von laevulinsaeure.
CH550133A (de) Verfahren zur herstellung von 4-methyl-pentanol-2-crotonat.
CH522961A (de) Verfahren zur Herstellung isolierter Halbleiterbereiche
AT301486B (de) Verfahren zur Herstellung von Phosphorsäure
CH551373A (de) Verfahren zur herstellung von bronchospasmolytisch wirksamen verbindungen.
AT307747B (de) Verfahren zur Herstellung von Polykondensationsprodukten aus Hydroxymethyl-phosphoniumverbindungen
CH550214A (de) Verfahren zur herstellung von cyclocopolymerisaten.
AT299974B (de) Verfahren zur Herstellung von Nitrilo-tris-(methylenphosphonsäure)
CH529128A (de) Verfahren zur Herstellung von Tetronsäure
AT303093B (de) Verfahren zur Herstellung von gekörnten Düngemitteln
CH558385A (de) Verfahren zur herstellung von ungesaettigten phosphorhaltigen carbonsaeurederivaten.
CH553242A (de) Verfahren zur herstellung von fluoreszierenden verbindungen.
CH539021A (de) Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH534667A (de) Verfahren zur Herstellung von Verbindungen, die die Bildung von Magensäure hemmen
CH547775A (de) Verfahren zur herstellung von diaethylaminopropionaniliden.
CH549567A (de) Verfahren zur herstellung von 8-cyano-5-octanolid.
CH558800A (de) Verfahren zur herstellung von chinazolinonen.
CH557830A (de) Verfahren zur herstellung von 1-aminosiochinolinen.
CH557327A (de) Verfahren zur herstellung von neuen 1-methylaminoalkyliden-benzocycloalkan-2-spirocycloaliphatischen verbindungen.
CH515783A (de) Verfahren zur Herstellung hygienisch-sanitärer Geräte
AT310462B (de) Verfahren zur Herstellung intermetallischer Verbindungen
CH553744A (de) Verfahren zur herstellung aromatischer dinitrohalogenverbindungen.

Legal Events

Date Code Title Description
PL Patent ceased